Diabetic retinal disease is envisioned to become the plague of the coming decades with a
steep increase of worldwide diabetes incidence followed by a substantial rise in retinal …

Management of center-involving diabetic macular edema represents a real therapeutic
challenge. Diabetic macular edema is the leading cause of visual acuity impairment in …

Purpose To investigate the relationship between baseline number of hyperreflective foci
(HF) on spectral domain optical coherence tomography (SD-OCT) in patients with diabetic …

Anti-VEGF drugs are as the first-line therapies for diabetic macular edema (DME). In this
study, we investigated the association between hyperreflective foci in the outer retinal layers …

Aims To describe baseline characteristics and visual outcome for eyes treated with
ranibizumab for diabetic macular oedema (DMO) from a multicentre database. Methods …

Diabetic retinopathy (more specifically diabetic macular edema, DME) is the most common
cause of loss of vision in the working population in developed countries. Anti-vascular …

Anti-vascular endothelial growth factor drugs are the first-line treatment for diabetic macular
edema (DME), although the mechanism of the visual acuity (VA) improvement remains …

Diabetic macular edema (DME) is a serious condition that can cause blindness in diabetic
patients suffering from diabetic retinopathy (DR). Although vascular endothelial growth factor …

Purpose: The aim of this consensus article was to provide comprehensive recommendations
in the management of diabetic macular edema (DME) by reviewing recent clinical evidence …

This overview introduces contributions to a special issue on causes of vision loss from
diabetes mellitus, focusing on the retina and also the cornea. Diabetic retinopathy is the …